As it has been speculated that CD19 mediated neurotoxicity may be due to off-target toxicity related to the expression of CD19 on brain mural cells57, our lower rates of toxicity may be partially related to the CD20 engagement of tumor. This evidence concerns the gene CD19 and neoplasm.